Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply

Brain Research Reviews

Volumn 43, Issue 1, 2003, Pages 164-178

  Atwood, Craig S ^a,b   Bowen, Richard L ^c   Smith, Mark A ^b   Perry, George ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Voyager Pharmaceutical Corporation   (United States)

Author keywords

Amyloid ; Anti coagulant; Blood supply; Blood brain barrier; Cerebrovasculature; Hemorrhage; Sealant; Vascular integrity

Indexed keywords

BLOOD BRAIN BARRIER; BLOOD CLOTTING; BRAIN BLOOD VESSEL; BRAIN PERFUSION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL VIABILITY; ENCEPHALITIS; EXTRACELLULAR MATRIX; HUMAN; IMMUNITY; IN VIVO STUDY; MENINGITIS; NERVE CELL; NERVE CELL DIFFERENTIATION; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOCYTE AGGREGATION; VACCINATION; VASCULARIZATION;

EID: 0141518676     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(03)00206-6     Document Type: Review

References (149)

1. Akar C.A., Wallace W.C. Amyloid precursor protein modulates the interaction of nerve growth factor with p75 receptor and potentiates its activation of trkA phosphorylation. Mol. Brain Res. 56:(1-2):1998;125-132.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
3. Araki W., Kitaguchi N., Tokushima Y., Ishii K., Aratake H., Shimohama S., Nakamura S., Kimura J. Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. Biochem. Biophys. Res. Commun. 181:1991;265-271.
4. Atwood C.S., Huang X., Moir R.D., Bacarra N.M., Romano D., Tanzi R.E., Bush A.I. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:1998;12817-12826.
5. Atwood C.S., Huang X., Moir R.D., Tanzi R.E., Bush A.I. The role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Sigel A., Sigel H. Interrelations between Free Radicals and Metal Ions in Life Processes. Metal Ions in Biological Systems. vol. 36:1999;309-364 Marcel Dekker, New York.
6. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., Bush A.I. Characterization of copper interactions with Alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75:2000;1219-1233.
7. Atwood C.S., Robinson S.R., Smith M.A. Amyloid-beta: redox-metal chelator and antioxidant. J. Alzheimer's Dis. 4:2002b;203-214.
8. Atwood C.S., Perry G., Smith M.A., Pfeifer M., Boncristiano S., Bondolfi L., Stalder A., Deller T., Staufenbiel M., Mathews P.M., Jucker M. Cerebral hemorrhage and amyloid-beta. Science. 299:2003;1014.
9. Atwood C.S., Bishop G.M., Perry G., Smith M.A. Amyloid-beta: a vascular sealant that protects against hemorrhage? J. Neurosci. Res. 70:2002a;356.
10. Atwood C.S., Huang X., Moir R.D., Smith M.A., Tanzi R.E., Roher A.E., Bush A.I., Perry G. Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits. Iqbal K., Sisodia S.S., Winblad B. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. 2001;341-361 Wiley, London.
11. Balin B.J., Gerard H.C., Arking E.J., Appelt D.M., Branigan P.J., Abrams J.T., Whittum-Hudson J.A., Hudson A.P. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl). 187:1998;23-42.
12. Bar T. The vascular system of the cerebral cortex. Adv. Anat. Embryol. Cell Biol. 59:1980;1-62.
13. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., Fallon J.R., Stopa E.G. Agrin and microvascular damage in Alzheimer's disease. Neurobiol. Aging. 21:2000;349-355.
14. Boero J.A., Ascher J., Arregui A., Rovainen C., Woolsey T.A. Increased brain capillaries in chronic hypoxia. J. Appl. Physiol. 86:1999;1211-1219.
15. Bornebroek M., Haan J., Roos R.A. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): a review of the variety in phenotypic expression. Amyloid. 6:1999;215-224.
16. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 6:1992;3345-3353.
17. Brown W.R., Moody D.M., Thore C.R., Challa V.R. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann. NY Acad. Sci. 903:2000;39-45.
18. Brunden K.R., Richter-Cook N.J., Chaturvedi N., Frederickson R.C. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J. Neurochem. 61:1993;2147-2154.
19. Buee L., Hof P.R., Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann. NY Acad. Sci. 826:1997;7-24.
20. Busciglio J., Gabuzda D.H., Matsudaira P., Yankner B.A. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA. 90:1993;2092-2096.
21. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., Currie J., Ames D., Weidemann A., Fischer P., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265:(26):1990;15977-15983.
22. Bush A.I., Pettingell W.H. Jr., Paradis M.D., Tanzi R.E. Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269:1994;12152-12158.
23. Bush A.I., Pettingell W.H., Multhaup G., d Paradis M., Vonsattel J.P., Gusella J.F., Beyreuther K., Masters C.L., Tanzi R.E. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science. 265:1994;1464-1467.
24. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.H., Abramowski D., Sturchler-Pierrat C., Sommer B., Staufenbiel M., Jucker M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA. 23:(24):1999;14088-14093.
25. Cervos-Navarro J., Gertz H.J., Frydl V. Cerebral blood vessel changes in old people. Mech. Ageing Dev. 39:1987;223-231.
26. Chan C.-W., Dharmarajan A., Atwood C.S., Huang X., Tanzi R.E., Bush A.I., Martins R.N. Anti-apoptotic action of Alzheimer Aβ Alzheimer's Rep. 2:1999;1-6.
27. Claudio L. Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol. (Berl.). 91:1996;6-14.
28. Clinton J., Ambler M.W., Roberts G.W. Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17:1991;69-74.
29. Coria F., Larrondo-Lillo M., Frangione B. Degeneration of smooth muscle cells in beta-amyloid angiopathies. J. Neuropathol. Exp. Neurol. 48:1989;368-375.
30. Cosgaya J.M., Latasa M.J., Pascual A. Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells. J. Neurochem. 67:1996;98-104.
31. Curtain C.C., Ali F.E., Smith D.G., Bush A.I., Masters C.L., Barnham K.J. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid. J. Biol. Chem. 278:2003;2977-2982.
32. Davies T.A., Long H.J., Sgro K., Rathbun W.H., McMenamin M.E., Seetoo K., Tibbles H., Billingslea A.M., Fine R.E., Fishman J.B., Levesque C.A., Smith S.J., Wells J.M., Simons E.R. Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol. Aging. 18:(2):1997;147-153.
33. De Jong G.I., Farkas E., Stienstra C.M., Plass J.R., Keijser J.N., de la Torre J.C., Luiten P.G. Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment. Neuroscience. 91:1999;203-210.
34. De la Torre J.C. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. NY Acad. Sci. 826:1997;75-91.
35. Dong J., Atwood C.S., Anderson V.E., Siedlak S.L., Perry G., Smith M.A., Carey P.R. Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence. Biochemistry. 42:2003;2768-2773.
36. Du Y., Ni B., Glinn M., Dodel R.C., Bales K.R., Zhang Z., Hyslop P.A., Paul S.M. alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J. Neurochem. 69:1997;299-305.
37. Exley C., Korchazhkina O.V. Plasmin cleaves Abeta42 in vitro and prevents its aggregation into beta-pleated sheet structures. Neuroreport. 12:2001;2967-2970.
38. Farkas E., De Vos R.A., Jansen Steur E.N., Luiten P.G. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol. Aging. 21:2000;235-243.
39. Fonte J., Miklossy J., Atwood C., Martins R. The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-beta Levels: Resolubilization of amyloid-beta with transition metal ion chelators. J. Alzheimer's Dis. 1:2001;209-219.
40. Frederikse P.H., Garland D., Zigler J.S., Piatigorsky J. Oxidative stress increases production of β-amyloid precursor protein and β-amyloid (A-beta) in mammalian lenses, and A-beta has toxic effects on lens epithelial cells. J. Biol. Chem. 271:1996;10169-10174.
41. Frenette P.S., Johnson R.C., Hynes R.O., Wagner D.D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc. Natl. Acad. Sci. USA. 92:1995;7450-7454.
42. Fukami S., Watanabe K., Iwata N., Haraoka J., Lu B., Gerard N.P., Gerard C., Fraser P., Westaway D., St. George-Hyslop P., Saido T.C. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci. Res. 43:2002;39-56.
43. Fukuchi K., Kamino K., Deeb S.S., Smith A.C., Dang T., Martin G.M. Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem. Biophys. Res. Commun. 182:1992;165-173.
44. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269:1994;13623-13628.
45. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., Roberts G.W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160:1993;139-144.
46. Harik S.I., Hritz M.A., LaManna J.C. Hypoxia-induced brain angiogenesis in the adult rat. J. Physiol. 485:1995;525-530.
47. Heber S., Herms J., Gajic V., Hainfellner J., Aguzzi A., Rulicke T., von Kretzschmar H., von Koch C., Sisodia S., Tremml P., Lipp H.P., Wolfer D.P., Muller U. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20:2000;7951-7963.
48. Heidland A., Sebekova K., Schinzel R. Advanced glycation end products and the progressive course of renal disease. Am. J. Kidney Dis. 38:2001;S100-106.
49. Horsburgh K., Cole G.M., Yang F., Savage M.J., Greenberg B.D., Gentleman S.M., Graham D.I., Nicoll J.A. Beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26:2000;124-132.
50. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Vonsattel J.-P., Tanzi R.E., Bush A.I. Zinc-induced Alzheimer's Aβ1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 272:1997;26464-26470.
51. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA. 95:1998;3275-3280.
52. Huizinga E.G., Tsuji S., Romijn R.A., Schiphorst M.E., de Groot P.G., Sixma J.J., Gros P. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science. 297:2002;1176-1179.
53. Hunziker O., Abdel'Al S., Frey H., Veteau M.J., Meier-Ruge W. Quantitative studies in the cerebral cortex of aging humans. Gerontology. 24:1978;27-31.
54. Hunziker O., Abdel'Al S., Frey H., Veteau M.J., Meier-Ruge W. The aging human cerebral cortex: a stereological characterization of changes in the capillary net. J. Gerontol. 34:1979;345-350.
55. Inoue S., Kisilevsky R. Beta-amyloid fibrils of Alzheimer's disease: pathologically altered, basement membrane-associated microfibrils? Ital. J. Anat. Embryol. 106:2001;93-102.
56. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., Saido T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 6:2000;143-150.
57. Iwata N., Takaki Y., Fukami S., Tsubuki S., Saido T.C. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70:2002a;493-500.
58. Iwata A., Chen X.H., McIntosh T.K., Browne K.D., Smith D. Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes. J. Neuropathol. Exp. Neurol. 61:2002b;1056-1068.
59. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Mol. Brain Res. 10:1991;299-305.
60. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72:1996;193-214.
61. Kawai M., Kalaria R.N., Cras P., Siedlak S.L., Velasco M.E., Shelton E.R., Chan H.W., Greenberg B.D., Perry G. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623:1993;142-146.
62. Keuker J.I., Luiten P.G., Fuchs E. Capillary changes in hippocampal CA1 and CA3 areas of the aging rhesus monkey. Acta Neuropathol. (Berl.). 100:2000;665-672.
63. Kingston I.B., Castro M.J., Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nature Med. 1:1995;138-142.
64. Kisilevsky R. Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis. Mol. Neurobiol. 8:1994;65-66.
65. Kontush A., Berndt C., Weber W., Akopyan V., Arlt S., Schippling S., Beisiegel U. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic. Biol. Med. 30:2001;119-128.
66. Kounnas M.Z., Loukinova E.B., Stefansson S., Harmony J.A., Brewer B.H., Strickland D.K., Argraves W.S. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270:1995;13070-13075.
67. Kraszpulski M., Tukaj C., Wrzolkowa T. Hippocampal capillaries in different age groups of chronically ethanol-intoxicated rats. Morphometrical studies. Folia Morphol. (Warsz.). 59:2000;121-129.
68. Kurochkin I.V., Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:1994;33-37.
69. Leblanc R., Haddad G., Robitaille Y. Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery. 31:1992;586-590.
70. Ledesma M.D., Da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., Dotti C.G. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep. 1:2000;530-535.
71. Little S., Hammond C., MacIntyre A., Balin B Appelt D. Induction of Alzheimer's disease-like pathology in the brains of young, non-transgenic, balb/c mice following infection with chlamydia pneumoniae: a model for late onset/sporadic Alzheimer's disease. Abstract No. 87 of the 8th International Conference on Alzheimer's Disease and Related Disorders. 2002.
72. Liu Y. Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostatis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 23:1999;377-395.
73. Lokkegaard A., Nyengaard J.R., West M.J. Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal region. Hippocampus. 11:2001;726-740.
74. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158:1998;47-52.
75. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y., Martin L., Louis J.C., Yan Q., Richards W.G., Citron M., Vassar R. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neurosci. 4:2001;231-232.
76. MacIntyre A., Little S., Hammond C., Appelt D., Balin B. Effects of chlamydia pneumoniae infection on the junctional complexes of the blood-brain barrier: implications for the pathogenesis of Alzheimer's disease. Abstract No. 1604 of the 8th International Conference on Alzheimer's Disease and Related Disorders. 2002.
77. Macfarlane D.P., Nicoll J.A., Smith C., Graham D.I. APOE epsilon4 allele and amyloid beta-protein deposition in long term survivors of head injury. Neuroreport. 10:1999;3945-3948.
78. Mahdi F., Van Nostrand W.E., Schmaier A.H. Protease nexin-2/amyloid β-protein precursor inhibits Factor Xa in the prothrombinase complex. J. Biol. Chem. 270:1995;23468-23474.
79. Mattson M.P., Guo Q., Furukawa K., Pedersen W.A. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70:1998;1-14.
80. Miller G. Breaking down barriers. Science. 297:2002;1116-1118.
81. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9:1992;129-137.
82. Misonou H., Morioshima-Kawashima M., Ihara Y. Oxidative stress induces intracellular accumulation of Alzheimer amyloid-β in human neuroblastoma cells. Soc. Neurosci. Abstr. 25:1999;340.
83. Miura T., Suzuki K., Kohata N., Takeuchi H. Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry. 39:2000;7024-7031.
84. Miyakawa T., Kimura T., Hirata S., Fujise N., Ono T., Ishizuka K., Nakabayashi J. Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease. Ann. NY Acad. Sci. 903:2000;46-54.
85. Moody D.M., Brown W.R., Challa V.R., Ghazi-Birry H.S., Reboussin D.M. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann. NY Acad. Sci. 826:1997;103-116.
86. Mori T., Wang X., Kline A.E., Siao C.J., Dixon C.E., Tsirka S.E., Lo E.H. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport. 12:2001;4117-4120.
87. Mrak R.E., Griffin S.T., Graham D.I. Aging-associated changes in human brain. J. Neuropathol. Exp. Neurol. 56:(12):1997;1269-1275.
88. Mucke L., Masliah E., Johnson W.B., Ruppe M.D., Alford M., Rockenstein E.M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C.R. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
89. Narindrasorasak S., Lowery D., Gonzalez-DeWhitt P., Poorman R.A., Greenberg B., Kisilevsky R. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266:1991;12878-12883.
90. Narita M., Holtzman D.M., Schwartz A.L., Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911.
91. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Med. 1:1995;135-137.
92. Nitsch R.M., Wollmer M.A., Poirier R., Mohajeri H. Role of neprilysin in preventing amyloid formation. Abstract No. 554 of the 8th International Conference on Alzheimer's Disease and Related Disorders. 2002.
93. Otsuka N., Tomonaga M., Ikeda K. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568:1991;335-338.
94. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U.M., Tabaton M., Pronzato M.A. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268:2000;642-646.
95. Pendlebury W.W., Iole E.D., Tracy R.P., Dill B.A. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann. Neurol. 29:1991;210-213.
96. Perlmutter L.S., Chui H.C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res. Bull. 24:1990;677-686.
97. Pfeifer L.A., White L.R., Ross G.W., Petrovitch H., Launer L.J. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 58:2002;1629-1634.
98. Piotrowski P., Gajkowska B., Olszewska H., Smialek M. Electron microscopy studies on experimental diabetes and cerebral ischemia in the rat brain. Folia Neuropathol. 37:1999;256-263.
99. Pluta R., Barcikowska M., Misicka A., Lipkowski A.W., Spisacka S., Januszewski S. Ischemic rats as a model in the study of the neurobiological role of human beta-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain. Neuroreport. 10:1999;3615-3619.
100. Poduslo J.F., Curran G.L., Wengenack T.M., Malester B., Duff K. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8:2001;555-567.
101. Prior R., D'Urso D., Frank R., Prikulis I., Pavlakovic G. Loss of vessel wall viability in cerebral amyloid angiopathy. Neuroreport. 7:1996;562-564.
102. Raby C.A., Morganti-Kossmann M.C., Kossmann T., Stahel P.F., Watson M.D., Evans L.M., Mehta P.D., Spiegel K., Kuo Y.M., Roher A.E., Emmerling M.R. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid. J. Neurochem. 71:1998;2505-2509.
103. Rebeck G.W., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37:1995;211-217.
104. Roberts G.W., Allsop D., Bruton C. The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry. 53:1990;373-378.
105. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., Graham D.I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;419-425.
106. Roberts G.W., Gentleman S.M., Lynch A., Graham D.I. beta A4 amyloid protein deposition in brain after head trauma. Lancet. 338:1991;1422-1423.
107. Roch J.M., Masliah E., Roch-Levecq A.C., Sundsmo M.P., Otero D.A., Veinbergs I., Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. USA. 91:1994;7450-7454.
108. Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., Ball M.J. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;10836-10840.
109. Sabo S.L., Ikin A.F., Buxbaum J.D., Greengard P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153:2001;1403-1414.
110. Saido T.C. Identification and utilization of Aβ-degrading peptidases. Abstract No. 553 of the 8th International Conference on Alzheimer's Disease and Related Disorders. 2002.
111. Saitoh T., Sundsmo M., Roch J.M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D.B. Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622.
112. Savage B., Saldivar E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84:1996;289-297.
113. Sayre L.M., Perry G., Harris P.L., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74:2000;270-279.
114. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
115. Schmaier A.H., Amenta S., Xiong T., Heda G.D., Gewirtz A.M. Expression of platelet C1 inhibitor. Blood. 82:1993;465-474.
116. Schmaier A.H., Dahl L.D., Hasan A.A.K., Cines D.B., Van Nostrand W.E. Factor IXa inhibition by protease nexin-2/amyloid β-protein precursor on phospholipid vesicles and cell membranes. Biochemistry. 34:1995;1171-1178.
117. Schmaier A.H., Dahl L.D., Rozemuller A.J.M., Roos R.A.C., Wagner S.L., Chung R., Van Nostrand W.E. Protease nexin-2/amyloid β-protein precursor: a tight binding inhibitor of coagulation factor IXa. J. Clin. Invest. 92:1993a;2540-2545.
118. Schmidt A.M., Hasu M., Popov D., Zhang J.H., Chen J., Yan S.D., Brett J., Cao R., Kuwabara K., Costache G., et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA. 91:1994;8807-8811.
119. Selkoe D.J. The life cycle of Aβ: production and degradation. Abstract No. 552 of the 8th International Conference on Alzheimer's Disease and Related Disorders. 2002.
120. Sirevaag A.M., Black J.E., Shafron D., Greenough W.T. Direct evidence that complex experience increases capillary branching and surface area in visual cortex of young rats. Brain Res. 471:1988;299-304.
121. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA. 94:1997;9866-9868.
122. Smith D.H., Nakamura M., McIntosh T.K., Wang J., Rodriguez A., Chen X.H., Raghupathi R., Saatman K.E., Clemens J., Schmidt M.L., Lee V.M., Trojanowski J.Q. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am. J. Pathol. 153:1998;1005-1010.
123. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 12:1994;219-234.
124. Takashima S., Kuruta H., Mito T., Nishizawa M., Kunishita T., Tabira T. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome cases. Brain Dev. 12:1990;367-371.
125. Tucker H.M., Kihiko-Ehmann M., Wright S., Rydel R.E., Estus S. Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition. J. Neurochem. 75:2000a;2172-2177.
126. Tucker H.M., Kihiko M., Caldwell J.N., Wright S., Kawarabayashi T., Price D., Walker D., Scheff S., McGillis J.P., Rydel R.E., Estus S. The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 20:2000b;3937-3946.
127. Tucker H.M., Kihiko M., Caldwell J.N., Wright S., Kawarabayashi T., Price D., Walker D., Scheff S., McGillis J.P., Rydel R.E., Estus S. The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 20:2000;3937-3946.
128. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., Lee V.M., Trojanowski J.Q. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454.
129. Van Nostrand W.E., Porter M. Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry. 38:1999;11570-11576.
130. Van Nostrand W.E., Schmaier A.H., Farrow J.S., Cunningham D.D. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science. 248:1990a;745-748.
131. Van Nostrand W.E., Melchor J., Wagner M., Davis J. Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall. Ann. NY Acad. Sci. 903:2000;89-96.
132. Van Nostrand W.E., Schmaier A.H., Farrow J.S., Cunningham D.D. Platelet protease nexin-2/amyloid beta-protein precursor. Possible pathologic and physiologic functions. Ann. NY Acad. Sci. 640:1991b;140-144.
133. Van Nostrand W.E., Farrow J.S., Wagner S.L., Bhasin R., Goldgaber D., Cotman C.W., Cunningham D.D. The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2. Proc. Natl. Acad. Sci. USA. 88:1991a;10302-10306.
134. Van Nostrand W.E., Wagner S.L., Farrow J.S., Cunningham D.D. Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. J. Biol. Chem. 265:1990b;9591-9594.
135. Van Nostrand W.E., Wagner S.L., Suzuki M., Choi B.H., Farrow J.S., Geddes J.W., Cotman C.W., Cunningham D.D. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 341:1989;546-549.
136. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke. 18:1987;311-324.
137. Vinters H.V., Secor D.L., Read S.L., Frazee J.G., Tomiyasy U., Stanley T.M., Ferreiro J.A., Akers M.-A. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct. Pathol. 18:1994;333-348.
138. Wakui K., Seguchi K., Kuroyanagi T., Sakai T., Tanaka Y., Kamijoh Y., Shiozawa Z. [Multiple intracerebral hemorrhages due to cerebral amyloid angiopathy after head trauma]. No Shinkei Geka. 16:1988;1287-1291.
139. Mori T., Wang X., Kline A.E., Siao C.J., Dixon C.E., Tsirka S.E., Lo E.H. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport. 12:2001;4117-4120.
140. Weller R.O., Massey A., Newman T.A., Hutchings M., Kuo Y.M., Roher A.E. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 153:1998;725-733.
141. Whitson J.S., Selkoe D.J., Cotman C.W. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science. 243:1989;1488-1490.
142. Williams S.E., Kounnas M.Z., Argraves K.M., Argraves W.S., Strickland D.K. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview. Ann. NY Acad. Sci. 737:1994;1-13.
143. Winkler D.T., Bondolfi L., Herzig M.C., Jann L., Calhoun M.E., Wiederhold K.H., Tolnay M., Staufenbiel M., Jucker M. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J. Neurosci. 21:2001;1619-1627.
144. Winkler D.T., Biedermann L., Tolnay M., Allegrini P.R., Staufenbiel M., Wiessner C., Jucker M. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann. Neurol. 51:2002;790-793.
145. Wnendt S., Wetzels I., Gunzler W.A. Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase. Thromb. Res. 85:1997;217-224.
146. Yamamoto K., Miyoshi T., Yae T., Kawashima K., Araki H., Hanada K., Otero D.A., Roch J.M., Saitoh T. The survival of rat cerebral cortical neurons in the presence of trophic APP peptides. J. Neurobiol. 25:1994;585-594.
147. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sato S., Sun X., Tanaka N., Takashima A. New insights on how metals disrupt amyloid
148. Yoshikawa K., Aizawa T., Maruyama K. Neural differentiation increases expression of Alzheimer amyloid protein precursor gene in murine embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 171:1990;204-209.
149. Zou K., Gong J.S., Yanagisawa K., Michikawa M. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22:2002;4833-4841.